NIM
TEVA icon

NEOS Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

NEOS Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,331
Closed -$759K – 651
2025
Q4 		$759K Buy
+24,331
New +$599K ﹤0.01% 576
2025
Q3 		– Sell
-28,861
Closed -$484K – 649
2025
Q2 		$484K Hold
28,861
– – 0.01% 550
2025
Q1 		$444K Buy
28,861
+3,199
+12% +$57.1K 0.01% 524
2024
Q4 		$566K Hold
25,662
– – 0.01% 488
2024
Q3 		$462K Buy
25,662
+1,873
+8% +$32.8K 0.01% 501
2024
Q2 		$387K Buy
23,789
+3,857
+19% +$59.4K 0.02% 489
2024
Q1 		$281K Buy
+19,932
New +$251K 0.02% 501

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NEOS Investment Management's TEVA Position: Q1 2026 in Review

NEOS Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 24,331 shares — an estimated $759K sold.

NEOS Investment Management first reported a position in TEVA in Q1 2024 and held it in 7 quarters. The position peaked at $759K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • NEOS Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 24,331 Teva Pharmaceuticals shares in Q1 2026, an estimated $759K.
  • NEOS Investment Management first reported a position in Teva Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • NEOS Investment Management's Teva Pharmaceuticals position peaked at $759K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.